FIRST REGULAR SESSION

HOUSE BILL NO. 279

91ST GENERAL ASSEMBLY

INTRODUCED BY REPRESENTATIVES SHOEMYER, COPENHAVER, JOLLY, FARNEN,

CLAYTON AND WIGGINS (Co-sponsors).

Read 1st time January 4, 2001, and 1000 copies ordered printed.

TED WEDEL, Chief Clerk

0711L.01I

AN ACT

To amend chapter 191, RSMo, by adding thereto one new section relating to supplemental newborn screening.



Be it enacted by the General Assembly of the state of Missouri, as follows:

Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to be known as section 191.332, to read as follows:

191.332. 1. By January 1, 2002, the department of health shall, subject to appropriations, expand the newborn screening requirements in section 191.331 to include potentially treatable or manageable disorders, including but not limited to cystic fibrosis, galactosemia, biotinidase deficiency, congenital adrenal hyperplasia, maple syrup urine disease (MRUD) and other amino acid disorders, glucose-6-phosphate degydrogenase deficiency (G-6-PD), MCAD and other fatty acid oxidation disorders, methylmalonic acidemia, propionic acidemia, isovaleric acidemia, and glutaric acidemia Type I and other organic acid disorders.

2. The department of health may promulgate rules to implement the provisions of this section. No rule or portion of a rule promulgated pursuant to the authority of this section shall become effective unless it has been promulgated pursuant to chapter 536, RSMo.


Missouri House of Representatives